BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 8643394)

  • 21. Tailoring the peptide-binding specificity of an RNA by combinations of specificity-altering mutations.
    Sugaya M; Nishimura F; Katoh A; Harada K
    Nucleosides Nucleotides Nucleic Acids; 2008 May; 27(5):534-45. PubMed ID: 18569791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
    Luedtke NW; Tor Y
    Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure of the HIV-1 Rev response element alone and in complex with regulator of virion (Rev) studied by atomic force microscopy.
    Pallesen J; Dong M; Besenbacher F; Kjems J
    FEBS J; 2009 Aug; 276(15):4223-32. PubMed ID: 19583776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of a nuclear factor that specifically binds to the Rev response element (RRE) of human immunodeficiency virus type 1 (HIV-1).
    Vaishnav YN; Vaishnav M; Wong-Staal F
    New Biol; 1991 Feb; 3(2):142-50. PubMed ID: 2065010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assignment and modeling of the Rev Response Element RNA bound to a Rev peptide using 13C-heteronuclear NMR.
    Battiste JL; Tan R; Frankel AD; Williamson JR
    J Biomol NMR; 1995 Dec; 6(4):375-89. PubMed ID: 8563466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
    Urcuqui-Inchima S; CastaƱo ME; Hernandez-Verdun D; St-Laurent G; Kumar A
    Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid-state NMR data support a helix-loop-helix structural model for the N-terminal half of HIV-1 Rev in fibrillar form.
    Blanco FJ; Hess S; Pannell LK; Rizzo NW; Tycko R
    J Mol Biol; 2001 Nov; 313(4):845-59. PubMed ID: 11697908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro.
    Daly TJ; Cook KS; Gray GS; Maione TE; Rusche JR
    Nature; 1989 Dec; 342(6251):816-9. PubMed ID: 2481237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proflavine acts as a Rev inhibitor by targeting the high-affinity Rev binding site of the Rev responsive element of HIV-1.
    DeJong ES; Chang CE; Gilson MK; Marino JP
    Biochemistry; 2003 Jul; 42(26):8035-46. PubMed ID: 12834355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Derivation of primary sequences and secondary structures of rev responsive element from HIV-1 infected mothers and infants following vertical transmission.
    Ramakrishnan R; Ahmad N
    Virology; 2007 Mar; 359(1):201-11. PubMed ID: 17045321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definition of the RRE binding and activation domains of the caprine arthritis encephalitis virus Rev protein.
    Schoborg RV; Clements JE
    Virology; 1996 Dec; 226(1):113-21. PubMed ID: 8941328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of nuclease resistant circular RNA decoys for HIV-Tat and HIV-Rev by autocatalytic splicing.
    Puttaraju M; Been MD
    Nucleic Acids Symp Ser; 1995; (33):152-5. PubMed ID: 8643355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
    Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
    J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity in the binding of aminoglycosides to HIV-RRE RNA.
    Cho J; Rando RR
    Biochemistry; 1999 Jun; 38(26):8548-54. PubMed ID: 10387102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural dynamics of HIV-1 Rev and its complexes with RRE and 5S RNA.
    Lam WC; Seifert JM; Amberger F; Graf C; Auer M; Millar DP
    Biochemistry; 1998 Feb; 37(7):1800-9. PubMed ID: 9485305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereospecificity of short Rev-derived peptide interactions with RRE IIB RNA.
    Litovchick A; Rando RR
    RNA; 2003 Aug; 9(8):937-48. PubMed ID: 12869705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.
    Fang J; Kubota S; Yang B; Zhou N; Zhang H; Godbout R; Pomerantz RJ
    Virology; 2004 Dec; 330(2):471-80. PubMed ID: 15567440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequence-specific RNA binding by the HIV-1 Rev protein.
    Zapp ML; Green MR
    Nature; 1989 Dec; 342(6250):714-6. PubMed ID: 2556643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy.
    Duan L; Zhu M; Ozaki I; Zhang H; Wei DL; Pomerantz RJ
    Gene Ther; 1997 Jun; 4(6):533-43. PubMed ID: 9231069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.